Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thiazolidinediones”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Large-scale testing (Phase 3)Study completedNCT01001611
What this trial is testing

An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 173
Post-approval studies (Phase 4)Study completedNCT01223196
What this trial is testing

Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio 60
Not applicableStudy completedNCT00663143
What this trial is testing

Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation

Who this might be right for
Osteoporosis
Emory University 9
Large-scale testing (Phase 3)UnknownNCT00116792
What this trial is testing

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus
Gold, Herman K., MD 120
Testing effectiveness (Phase 2)Study completedNCT00609362
What this trial is testing

The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells

Who this might be right for
Change in Bone Mineral DensityChange in Bone Marrow Fat Content
University of Aarhus 57
Post-approval studies (Phase 4)Study completedNCT00402909
What this trial is testing

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

Who this might be right for
Type 2 Diabetes
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT00575874
What this trial is testing

Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Daiichi Sankyo Co., Ltd. 150
Post-approval studies (Phase 4)Study completedNCT00953498
What this trial is testing

Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins

Who this might be right for
Type 2 Diabetes
Centre Hospitalier Universitaire Dijon 40
Not applicableUnknownNCT00975169
What this trial is testing

Association Study of Genetic Polymorphisms of Candidate Genes With Thiazolidinedione-Related Peripheral Edema and Drug Responsiveness

Who this might be right for
Diabetes Mellitus
National Taiwan University Hospital 400
Large-scale testing (Phase 3)Study completedNCT00717457
What this trial is testing

Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 1,189
Testing effectiveness (Phase 2)Study completedNCT00743002
What this trial is testing

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Who this might be right for
Diabetes Mellitus, Type 2
OPKO Health, Inc. 87
Large-scale testing (Phase 3)UnknownNCT02265276
What this trial is testing

A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease

Who this might be right for
Fatty Liver
Command Hospital, India 100
Early research (Phase 1)Study completedNCT00285844
What this trial is testing

Integrating the Genetic and Metabolic Faces of Obesity

Who this might be right for
Insulin ResistanceObesityMetabolic Syndrome
Stanford University 88
Testing effectiveness (Phase 2)Ended earlyNCT00368017
What this trial is testing

Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Vanderbilt University 12
Large-scale testing (Phase 3)Study completedNCT00357370
What this trial is testing

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 163
Not applicableStudy completedNCT01147627
What this trial is testing

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2Newly Diagnosed
Sun Yat-sen University 416
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Testing effectiveness (Phase 2)Study completedNCT00241423
What this trial is testing

Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 30
Large-scale testing (Phase 3)Ended earlyNCT00203632
What this trial is testing

Glitazones and Endothelial Function (GATE)

Who this might be right for
Diabetes Mellitus
University of Calgary 40
Large-scale testing (Phase 3)Study completedNCT00396227
What this trial is testing

Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 2,665
Next Page